Skip to main content

Advertisement

SpringerLink
Log in

Sorafenib Combined with Locoregional Therapy Prior to Liver Transplantation for Hepatocellular Carcinoma: An Update on a Previous Case Report

  • Letter to the Editor
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–9.

    Article  PubMed  CAS  Google Scholar 

  2. Yao FY, Hirose R, LaBerge JM, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005;11:1505–14.

    Article  PubMed  Google Scholar 

  3. Vagefi PA, Hirose R. Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy? J Gastrointest Cancer. 2010;41(4):217–20.

    Article  PubMed  Google Scholar 

  4. Washburn K, Edwards E, Harper A, et al. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant. 2010;10(7):1643–8.

    Article  PubMed  CAS  Google Scholar 

  5. Hoffmann K, Glimm H, Radeleff B, et al. Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation–HeiLivCa. BMC Cancer. 2008;8:349.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

  1. Division of Transplant Surgery, Massachusetts General Hospital/Harvard Medical School, 55 Fruit Street, White 544b, Boston, MA, 02114, USA

    Parsia A. Vagefi

  2. Division of Transplantation, University of California, San Francisco, CA, USA

    Ryutaro Hirose

Authors
  1. Parsia A. Vagefi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryutaro Hirose
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Parsia A. Vagefi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vagefi, P.A., Hirose, R. Sorafenib Combined with Locoregional Therapy Prior to Liver Transplantation for Hepatocellular Carcinoma: An Update on a Previous Case Report. J Gastrointest Canc 44, 246–247 (2013). https://doi.org/10.1007/s12029-012-9417-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-012-9417-y

Keywords

Search

Navigation